References
- Dagklis IE, Papagiannopoulos S, Theodoridou V, Kazis D, Argyropoulou O, Bostantjopoulou S. Miller-Fisher syndrome: are Anti-GAD antibodies implicated in its pathophysiology? Case Rep Neurol Med. 2016;2016:3431849. doi:https://doi.org/10.1155/2016/3431849.
- Al Othman B, Raabe J, Kini A, Lee AG. Update: the Miller Fisher variants of Guillain-Barré syndrome. Curr Opin Ophthalmol. 2019;30(6):462–466. doi:https://doi.org/10.1097/ICU.0000000000000611.
- Truong J, Conley J, Ashurst J. Miller-Fisher syndrome: a case report and review of the literature. Clin Pract Cases Emerg Med. 2020;4(4):653–655. doi:https://doi.org/10.5811/cpcem.2020.7.48507.
- Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology. 1993;43(10):1911–1917. doi:https://doi.org/10.1212/WNL.43.10.1911.
- Liu JX, Willison HJ, Pedrosa-Domellöf F. Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles. Invest Ophthalmol Vis Sci. 2009;50(7):3226–3232. doi:https://doi.org/10.1167/iovs.08-3333.
- Teener JW. Miller Fisher’s syndrome. Semin Neurol. 2012;32(5):512–516. doi:https://doi.org/10.1055/s-0033-1334470.
- Jung JH, Oh EH, Shin JH, et al. Atypical clinical manifestations of Miller Fisher syndrome. Neurol Sci. 2019;40(1):67–73. doi:https://doi.org/10.1007/s10072-018-3580-2.
- Hess DC, Awad E, Posas H, Sethi KD, Adams RJ. Miller Fisher syndrome in systemic lupus erythematosus. J Rheumatol. 1990;17:1520–1522.
- Bingisser R, Speich R, Fontana A, Gmür J, Vogel B, Landis T. Lupus erythematosus and Miller-Fisher syndrome. Arch Neurol. 1994;51(8):828–830. doi:https://doi.org/10.1001/archneur.1994.00540200108024.
- Okoh HC, Lubana SS, Langevin S, Sanelli-Russo S, Abrudescu AA. Case of systemic lupus erythematosus presenting as Guillain-Barré syndrome. Case Rep Rheumatol. 2015;2015:528026. doi:https://doi.org/10.1155/2015/528026.
- Arimura H. Atypical Miller Fisher syndrome associated with antiphospholipid antibodies. Rinsho shinkeigaku = Clinical neurology. 2000;40(1):62; discussion 63.
- Ishida S, Ura M, Kameoka K, Furukawa K, Tagami M. A case of atypical Miller Fisher syndrome associated with antiphospholipid antibodies. Rinsho shinkeigaku = Clinical neurology. 1999;39(4):448–451.
- Mitoma H, Adhikari K, Aeschlimann D, et al. Consensus paper: neuroimmune mechanisms of cerebellar ataxias. Cerebellum. 2016;15(2):213–232. doi:https://doi.org/10.1007/s12311-015-0664-x.
- Englert H, Derue G, Hughes GR. Neurology and the lupus anticoagulant. Eur Neurol. 1985;24(6):422–425. doi:https://doi.org/10.1159/000115836.
- Sahebari M, Rastin M, Boostani R, Forughipour M, Hashemzadeh K, Sadeghi SH. Subtypes of antiphospholipid antibodies in neurologic disorders: an observational study. Curr Rheumatol Rev. 2019;15(1):59–66. doi:https://doi.org/10.2174/1573397114666180514125412.
- Harris EN, Englert H, Derve G, Hughes GR, Gharavi A. Antiphospholipid antibodies in acute Guillain-Barré syndrome. Lancet. 1983;2(8363):1361–1362. doi:https://doi.org/10.1016/S0140-6736(83)91113-3.
- Gilburd B, Stein M, Tomer Y, et al. Autoantibodies to phospholipids and brain extract in patients with the Guillain-Barre syndrome: cross-reactive or pathogenic? Autoimmunity. 1993;16(1):23–27. doi:https://doi.org/10.3109/08916939309010644.
- Labrador-Horrillo M, Martinez-Valle F, Gallardo E, Rojas-Garcia R, Ordi-Ros J, Vilardell M. Anti-ganglioside antibodies in patients with systemic lupus erythematosus and neurological manifestations. Lupus. 2012;21(6):611–615. doi:https://doi.org/10.1177/0961203312436856.